parallel analysis of translated open reading frames (orFs) (plato) can be used for the unbiased discovery of interactions between full-length proteins encoded by a library of 'prey' orFs and surface-immobilized 'bait' antibodies, polypeptides or small-molecular-weight compounds. plato uses ribosome display (rD) to link orF-derived mrna molecules to the proteins they encode, and recovered mrna from affinity enrichment is subjected to analysis using massively parallel Dna sequencing. compared with alternative in vitro methods, plato provides several advantages including library size and cost. a unique advantage of plato is that an alternative reverse transcription-quantitative pcr (rt-qpcr) protocol can be used to test binding of specific, individual proteins. to illustrate a typical experimental workflow, we demonstrate plato for the identification of the immune target of serum antibodies from patients with inclusion body myositis (IBM). Beginning with an orFeome library in an rD vector, the protocol can produce samples for deep sequencing or rt-qpcr within 4 d.
IntroDuctIon
Whether transient or long lived, protein-binding interactions are crucial to nearly every biological process. It is no surprise, therefore, that researchers have invested a great deal of effort toward developing and refining techniques for measuring these molecular events. Broadly, such methods tend to fall into one of two categories: unbiased interaction discovery or candidate interaction testing. Examples of the latter category are extremely common, and include co-precipitation of a candidate interactor (prey) with an immobilized bait protein, followed by candidate-specific immunodetection (i.e., immunoprecipitation-western blotting, IP-WB). In many cases, however, an investigator may be more interested in discovering novel protein-binding interactions to generate new hypotheses and experimental directions. Established techniques used for this purpose include in vivo yeast two-hybrid screening and in vitro protein microarrays analysis. IP-mass spectrometry is another method that has grown in popularity with technical advances in peptide fragment detection. When deciding among technologies that can be used in a protein interaction discovery project, we suggest considering the factors outlined in Table 1 .
We have recently developed PLATO as an alternative for analyzing protein interactions 1 . PLATO is unique as an in vitro method in that it can be implemented either in unbiased discovery mode or in single-candidate analysis mode ( Fig. 1) . It can be used to identify interactions between ORF-encoded proteins and any type of surface-immobilized bait molecule. Commonly used baits include proteins (for protein-protein interaction discovery), autoantibodies (for antigen determination) and drugs (for target identification). This protocol uses RD to physically link each ORF's mRNA to the polypeptide it encodes 2 . In theory, however, alternative in vitro display techniques such as mRNA display 3 could be readily adapted to PLATO. An important benefit of translating proteins in vitro is the capacity to produce protein products that would be toxic to host cells. Each display methodology has different tradeoffs in terms of genetic coupling efficiency and polypeptide length/compositional expression bias.
Limitations of the method
It is important to note that, compared with in vivo expression systems, proteins translated in vitro lack chaperone-assisted folding, post-translational modifications and a cellular context.
A second possible limitation concerns the use of nucleic acid baits and nucleic acid-binding baits. Although we have not tested these types of bait molecules in PLATO, we anticipate that binding of library mRNA will most likely mask the signal derived from protein interactions.
Experimental design
The PLATO protocol described here consists of three parts: (i) preparation of an RD ORFeome library, (ii) enrichment of the library on surface-immobilized bait ('panning') and (iii) conversion of recovered ORF mRNAs into 3′ tag DNA libraries for deep sequencing or qPCR analysis.
ORFeome display library preparation. PLATO takes as input a library of ORFs. Methods for preparing such a library are not provided here, but they can be found in the published literature [4] [5] [6] [7] [8] [9] . The human ORFeome collection, which we have used, was constructed by PCR cloning from cDNA libraries into the Gateway entry vector system [10] [11] [12] [13] . Importantly, during ORF amplification, native stop codons were PCR-mutated into coding sequences for the purpose of allowing the addition of C-terminal fusion tags to the expressed polypeptides. RD depends critically upon the absence of stop codons, and thus PLATO-compatible ORFeome libraries must be free of them.
Throughout the preparation of a PLATO library, we take several precautions to minimize the amount of ORF clone representational bias.
Discovery of protein interactions using parallel analysis of translated ORFs (PLATO)
Sequencing analysis of both the input and affinity-enriched libraries permits compensation for representational bias in silico, but skewed representation increases the sequencing depth required for sufficient sampling of lower-abundance ORFs. The most notable source of representational bias in the final ORF pool can be attributed to clone length, as increased transcript length results in lower recombination and amplification efficiencies. For this reason, we recommend making intermediate ORF subpools by combining entry clones of similar sizes. From the human ORFeome v5.1, which is composed of 15,483 clones, we created 18 subpools. These subpools of entry clones underwent recombination separately into pRD-DEST, and they were subsequently amplified by PCR using a universal set of primers. At this point, an equal molar ratio of PCR product from each subpool (calculated using each pool's average ORF length) can be combined into a single superpool. The superpooled PCR product is then used as template for in vitro T7 RNA polymerase transcription from the pRD-DEST promoter. As each ORF clone carries a single T7 promoter, and initiation is generally the rate-limiting step of transcription, clones of different length should be transcribed at approximately the same rate. For optimal RD performance, the 5′ and 3′ ends of the mRNA are composed of stabilizing stem loop structures (added during the PCR), which minimize mRNA degradation by contaminating exonuclease activity 14, 15 .
Many kits are available to couple transcription and translation in a single reaction. As the presence of ORF PCR products in the final display reaction may complicate downstream analysis, we highly recommend the preparation and then purification of in vitro-transcribed mRNA, before in vitro translation. Aliquots of transcribed mRNA can be stored at −80 °C for extended periods, but it is important to prepare a fresh RD translation product immediately before each selection. Cell-free lysates for in vitro translation can be prepared in-house or purchased from a commercial vendor 16 . We have tested rabbit reticulocyte lysate (Promega), the RTS 100 HY Escherichia coli lysate (5Prime) and a system of reconstituted E. coli translation machinery (NEB). In our hands, the RTS 100 HY system produced the most efficient recovery of positive control RD proteins. Notably, we have not tested wheat germ cell-free expression, which has been reported to perform very well for human protein production 17 . However, eukaryotic ribosomal complexes are less easily disrupted than their bacterial counterparts 18 , and thus additional optimization should be performed if these translation systems are used.
Panning the displayed ORFeome. Project-specific considerations will determine the best method by which bait molecules should be immobilized on the panning surface. We have exclusively used magnetic beads (protein A or protein G coated for antibodies, streptavidin coated for biotinylated compounds or glutathione coated for GSTtagged proteins), but alternative surface chemistries can also be used, provided they are rendered free of contaminating nucleases and made inert to the display library (by blocking, washing and/or inactivating reactive moieties). For panning on immobilized small molecules, it is essential to ensure that the linking moiety is of sufficient length to prevent steric hindrance from obscuring target interactions. If these conditions are met, PLATO can be used to identify protein interactions with a wide variety of bait types. Although surface immobilization of bait molecules is project specific, several considerations are shared by all PLATO projects. Perhaps most importantly, it is essential that RNase activity be eliminated from the panning process. Patient-derived antiserum and bacterially derived recombinant protein may harbor RNase activity, which should be minimized by extensive washing and then neutralized by the addition of an RNase inhibitor to both the blocking and binding buffers. We use a relatively simple qPCR-based method to monitor RNA integrity, which measures the relative abundance of 3′ and 5′ transcript ends after library enrichment. Intact transcripts will provide equal signals from their two termini, whereas panning of a degraded library will result in disproportionate loss of signal from the transcripts' 5′ end (due to the nonspecific adsorption of ribosomes and nascent polypeptides that retain their transcripts' 3′ ends). The ratio of 3′ to 5′ qPCR signal is thus an indicator of postpanning transcript integrity. Although mRNA degradation during panning does not affect the enrichment of displayed proteins, a differential amount of transcript degradation between samples may produce 3′ tag enrichment artifacts. We therefore recommend ensuring relatively uniform mRNA transcript integrity across samples so as to minimize such artifacts.
Optimum panning conditions are project-dependent, and they should be determined empirically. For this purpose, one will ideally use a positive control bait that is known to bind a particular prey present within the ORFeome library (or one that can be spiked into the ORFeome library). ORF-specific RT-qPCR can then be used to monitor enrichment of this target transcript relative to the starting library, while different panning conditions are explored. The most germane parameters to vary include the display library binding time and the composition of the wash buffer. Increased binding times may increase target transcript recovery, but they will also result in increased nonspecific library binding and potentially in an increase in mRNA degradation. We have found 6 h of binding to be a useful, general-purpose length of time, but it may not be ideal for all experimental setups. The stringency of the wash step can similarly have an important role in target enrichment efficiency. The number of washes and the wash buffer salt concentration suggested by this protocol should be considered as starting points for additional projectspecific optimization.
PLATO does not require ORF library 'pre-clearing' or 'negative panning' before positive panning on the bait of interest. Sequencing analysis of libraries enriched on appropriate negative control surfaces (e.g., GST-only-coated beads, healthy donor antibody-coated beads, biotin-linker-only-coated beads) will reveal the ORFeome library members that are specifically enriched by the intended bait molecules.
When panning of the library is complete, the next step is elution of the surface-bound mRNA. We have compared methods that use proteolysis, heat denaturation or chelation of divalent cations to elute displayed mRNA. In our hands, chelation at elevated temperatures (37 °C) resulted in the most efficient recovery of positive control prey transcripts. For bait molecules immobilized via cleavable moieties, post-panning linker cleavage is another good alternative for recovery of enriched mRNA. 
Preparation of enriched libraries for analysis.
Recovered mRNA transcripts must be converted to cDNA for analysis by qPCR and/or deep sequencing. For simple qPCR analysis, reverse transcription followed by standard SYBR green or TaqMan detection can be used to quantify enrichment. We recommend designing qPCR primers that are biased toward the 3′ terminus of the transcript so as to be minimally influenced by mRNA degradation. We typically initiate reverse transcription from a universal sequence downstream of the ORF (Fig. 2) , but in certain cases it may be advantageous to initiate reverse transcription using genespecific priming from within target ORFs. For unbiased analysis of the enriched library using deep sequencing, we recommend 3′ tag counting as the method of choice for three main reasons: (i) it minimizes the effect of 5′ end loss due to mRNA degradation; (ii) sequencing read depth is not biased toward longer transcripts; and (iii) tag counts are stoichiometric with transcript abundance, thus simplifying analysis. Panned mRNA should be chemically fragmented before performing reverse transcription with a universal primer. The resulting cDNA is then polyadenylated to allow the 3′ tag to be amplified during a subsequent nested PCR. Nesting the first PCR is essential to minimize interference from the reverse transcription primer, and we further recommend destroying this primer with an exonuclease before amplification. We have tested several polymerases for their amplification efficiency and found Herculase II (Agilent) to provide the least amount of length and %GC bias, which is consistent with other reports 19 . In an effort to further streamline this stage of the protocol, we are developing a second iteration of PLATO that incorporates ORF-specific barcodes into the 3′ terminus of the library. A more automationfriendly RT-PCR protocol can thus be used to produce a barcode amplicon for deep sequencing.
Illumina DNA sequencing libraries must have termini composed of universal 'P5' and 'P7' sequences, which are required for cluster generation. In our library preparation scheme, the first PCR (PCR1) adds the P5 sequence upstream of the TolA region of the cDNA, and a universal adaptor sequence is added upstream of the polyadenylation site ( Fig. 2) . This adaptor doubles as the standard Illumina 'indexing' primer binding sequence, and it is essential for multiplex sequencing of pooled libraries. In a second PCR (PCR2), P7 and a 7-nt sample-specific barcode are added upstream of the adaptor sequence. After amplification, the concentration of the PCR2 libraries are quantified by qPCR by using P5 and P7 primers, and they are then pooled for sequencing, preferably on an Illumina HiSeq series instrument. A custom sequencing primer must be used for the analysis, and it is essential that the first cycle of base addition be templated by ORF sequence (not the constant sequence outside of the ORF insert). Extreme imbalance in the nucleotide composition of the first several sequencing cycles can result in failed cluster definition. If multiple samples (with unique barcodes) are pooled for sequencing, it is essential that a second read from the universal indexing primer be obtained for sample deconvolution. In general, we recommend using a 50-nt, single-end sequencing protocol. Longer reads or matepaired reads are unnecessary, and they may complicate the alignment for reads arising from shorter mRNA fragments. The precision of any PLATO experiment is determined by the number of successfully aligned reads. We have found ~10 million reads per sample to be more than sufficient, and even ~1 million reads can detect robust enrichment of clones with reasonable representation in the starting library.
Analysis of sequencing data begins with the alignment of the reads against a reference database of ORFeome sequences. For this, we have used the Bowtie alignment software 20 with success, but other short-read aligners would also work. Implementation of alignment algorithms is beyond the scope of this protocol, but well-documented, open-source solutions are now widely available 21 . Conversion of alignments into tag counts is achieved by simply summing the number of alignments for each ORF. Finally, comparison of tag counts for each ORF across different conditions (including the non-enriched starting library and the library enriched on a negative control bait) permits the identification of specifically enriched clones. We have found that the simple, threshold-based, fold-change analysis presented here is usually sufficient to reveal the most highly enriched ORF clones. be caused by specific interactions with an ORF's transcript. It is therefore necessary to validate candidate, PLATO-predicted interactions using non-RD proteins. To this end, the candidate ORF must be subcloned into an expression vector for subsequent analysis. Preferably, the expression vector will encode a fusion tag for tracking the protein in validation experiments. Otherwise, an antibody directed against the candidate ORF must be obtained. Protein can be expressed in cell-free lysate or after transfection or transduction into an appropriate host cell. For illustrative purposes, we describe here the transient transfection of a standard expression plasmid into human embryonic kidney (HEK)
Validation of PLATO interactions
293T cells. As protein expression is not always predictable, it is essential to verify by WB that the candidate protein is produced in sufficient quantity. With candidate protein in hand, the most straightforward validation is affinity enrichment on bait-coated beads (IP-WB). We describe this method below. A number of equally viable approaches can also be used. For example, we use immunofluorescence to demonstrate how patient antibodies are able to specifically recognize a cell-expressed autoantigen (Fig. 3) .
ELISA, in-cell western assay and dot blotting are additional confirmatory methods that preserve candidate protein conformation during interaction testing. 
MaterIals
PBST, 1× Make a 1-liter solution of 3.2 mM Na 2 HPO 4 (0.454 g), 0.5 mM KH 2 PO 4 (0.068 g), 1.3 mM KCl (0.0969 g) and 135 mM NaCl (7.89 g) . Adjust the pH to 7.4 with NaOH or HCl. Add Tween 20 to 0.05% (vol/vol). Store the solution at 4 °C for up to 1 month. RIPA buffer, 1× Make a 1-liter solution of 50 mM Tris base (6.60 g) and 150 mM NaCl (8.77 g); adjust the pH to 7.4 with HCl. Add NP-40 to 1% (vol/vol), Na deoxycholate to 0.25% (wt/vol) and EDTA to 1 mM (0.292 g for 1 liter). Store the buffer at 4 °C for up to 6 months. E. coli lysis buffer Make a 1-liter solution of 50 mM Tris base (6.60 g) and 100 mM NaCl (5.84 g); adjust the pH to 8.0 with HCl. Add EDTA to 0.5 mM (0.146 g), MgCl 2 to 5 mM (1.02 g), NP-40 to 0.2% (wt/vol), DTT to 2 mM (0.308 g), PMSF to 0.2 mM (0.0348 g), lysozyme to 200 µg ml −1 and protease inhibitor cocktail to 1×. Store the buffer at 4 °C for up to 1 week. GST wash buffer I Make a 1-liter solution of 50 mM Tris base (6.60 g), 500 mM NaCl (29.2 g) and 1 mM EGTA (0.380 g); adjust the pH to 7.5 with HCl. Add glycerol to 10% (vol/vol), Triton X-100 to 0.1% (vol/vol), β-mercaptoethanol to 0.1% (vol/vol) and PMSF to 1 mM (0.174 g). Store the buffer at 4 °C for up to 1 month. GST wash buffer II Make a 1-liter solution of 50 mM HEPES (11.9 g), 100 mM NaCl (5.84 g) and 1 mM EGTA (0.380 g); adjust the pH to 7.5. Add glycerol to 10% (vol/vol), β-mercaptoethanol to 0.1% (vol/vol) and PMSF to 1 mM (0.174 g). Store the buffer at 4 °C for up to 1 month. We recommend using molecular biology-grade acetylated BSA.
(B) Immobilization of Gst fusion protein-coated beads  crItIcal step
The following is used for inducible protein expression from pET-DEST42 in BL21(DE3) E. coli cells.
(i) Induce the expression of GST fusion protein in a 50-ml culture volume with 0.1 mM IPTG at 30 °C for 4 h (conditions depend on the bait protein of interest). Lysate from cells expressing GST only (i.e., no fusion protein) should be used as a negative control. (ii) Pellet cells at 4,000g for 10 min at 4 °C and then lyse them in 5 ml of lysis buffer on ice for 1 h. (iii) Sonicate the lysate on ice (see sonicator setup in the Equipment Setup section). (iv) Centrifuge the lysate at 4,000g for 10 min at 4 °C and retain the supernatant.
(v) Incubate 0.5 ml of MagneGST glutathione particles with ~ 5 ml of lysate at 4 °C for 4 h. GST alone should be used as negative control bait. (vi) Wash beads with GST wash buffer I three times and then with GST wash buffer II three times. Aliquots of 50 µl of coated beads can be stored at −80 °C for up to 1 month. (vii) Allow beads to collect in the magnetic stand for 30 s before aspirating the buffer. Remove the tube from the stand and resuspend the beads in 500 µl of RD wash buffer by pipetting up and down ten times. Repeat this step five times, replacing tubes between each wash. (c) Immobilization of biotinylated molecules using streptavidin-coated beads (i) Immobilize compounds directly on magnetic beads by using previously described procedures 22 . Biotinylated compounds can be immobilized on Dynabeads MyOne streptavidin T1 magnetic beads by incubation in 1× PBST at 4 °C overnight. Separately, immobilize an equal amount of biotin alone as a negative control. Generally, we immobilize ~2-20 µmol of compound per 1 ml of beads and use 25 µl of beads for a pull-down experiment. A sample that contains excess competitor (at least 10× the number molecules as that on the beads), nonbiotinylated compound should be included as an additional negative control. The competitor compound can be added to the display library (Step 15, below) before mixing it with the bait-immobilized beads. (ii) Allow beads to collect in the magnetic stand for 30 s before aspirating the buffer. Remove the tube from the stand and resuspend the beads in 500 µl of RD wash buffer by pipetting up and down ten times. Repeat this step five times, replacing tubes between each wash. 15| Dilute 12.5-µl aliquots of the translation product in 85.5 µl of ice-cold RD selection buffer containing 2 µl of RNaseOUT RNase inhibitor. Centrifuge the reaction mixture at 14,000g for 5 min at 4 °C. Remove the supernatant to a new, ice-cold 1.5-ml tube.  crItIcal step It is essential that the translation mix be kept at or below 4 °C (but not allowed to freeze) until enriched transcripts are eluted from the beads (Step 18).
16| Allow the beads (from Step 13) to collect in the magnetic stand for 30 s before aspirating the RD selection buffer. Remove the tube from the stand and resuspend the beads in 100 µl of RD translation mix (Step 15) . Incubate the beads at 4 °C for 6 h while rotating end-over-end.
17| Allow the beads to collect in the magnetic stand for 30 s before aspirating the buffer. Remove the tube from the stand and resuspend the beads in 500 µl of RD wash buffer by pipetting up and down ten times. Repeat this step five times, replacing tubes between each wash.
rna recovery and quality control • tIMInG ~6 h 18| Allow the beads to collect in the magnetic stand for 30 s before aspirating the buffer. Remove the tube from the stand and disrupt the ribosomal complexes by resuspending the beads in 50 µl of EB20 elution buffer containing 1 µl of RNaseOUT RNase inhibitor at 37 °C for 10 min.
? trouBlesHootInG 19| Purify the eluted mRNA on RNeasy columns according to the manufacturer's instructions.  pause poInt RNA can be stored at −80 °C for up to 2 years.
20|
The quality and amount of eluted mRNA is determined by RT-qPCR. Make a dilution series (down to 1:10,000) of the in vitro-transcribed 'input' mRNA (from Step 11) . Reverse-transcribe a small aliquot (e.g., 10-20%) of both the eluted and input mRNA samples by using the primer TolART (0.1 µM final concentration) and the SuperScript III reverse transcriptase according to the manufacturer's instructions.
21|
The quality control (QC) primer pair ORF5QCF and ORF5QCR is used to monitor the abundance of the 5′ ends of the transcripts, whereas the primer pair ORF3QCF and ORF3QCR is used to monitor the abundance of the 3′ ends. For the 5′ primer pair, assemble the following reaction: Figure 3 illustrates the key outputs from a successful PLATO-based autoantigen discovery project. In this example, serum samples were obtained from patients with IBM, an autoimmune disease of the skeletal muscles. It has recently been reported that over half of the patients with IBM harbor antibodies targeting the cytosolic 5′-nucleotidase 1A protein (NT5C1A), and that the presence of these antibodies are of diagnostic value for IBM 23, 24 . As described in Step 12A above, we immobilized serum antibodies from IBM patients or healthy donors on protein A-and protein G-coated magnetic beads acting as bait, and then followed the protocol. We ran the product of the PCR2 (Step 39) on a 2% (wt/vol) agarose gel and observed smeared bands of ~200 bp in length (Fig. 3a) . Poor amplification will not yield observable material, whereas amplification of primer dimers alone will result in a sharp band below 75 bp in size. We pooled the indexed libraries and submitted them to a sequencing facility for single-end, 50-cycle, multiplex sequencing on an Illumina HiSeq 2000 system with the custom sequencing primer PRDREV-attB2-SP. At least 2 million reads were obtained for each sample after alignment against the reference ORFeome database. Reads corresponding to each ORF were aggregated and the counts for each ORF are shown as a scatter plot to compare the relative abundance after panning on IBM antibodies versus on healthy donor antibodies (Fig. 3b,c) . An IBM-enrichment score was calculated for each ORF that had an IP read count above 50. In both patients, NT5C1A was among the two most enriched ORFs, and it was enriched by none of the healthy donors. Enrichment of NT5C1A was then specifically assayed by using ORF-specific RT-qPCR (Fig. 3d) , and the amount of enrichment detected corresponded well with that determined by deep sequencing (approximately tenfold). We next used immunofluorescence to confirm that IBM antisera indeed recognize FLAG-tagged NT5C1A expressed in human cells (Fig. 3e) . Notably, we observed that overexpressed NT5C1A accumulates in perinuclear protein aggregates, thus suggesting a pathological role in the myonuclear degeneration that is characteristic of the disease. 
